It is a myeloproliferative disease characterized by the presence of a molecular rearrangement, known as the Philadelphia chromosome (Ph), that generates a BCR/ABL fusion gene and the production of the BCR/ABL fusion protein with tyrosine kinase activity. This evidence concerns the gene BCR and myeloproliferative disorder.